Stockreport

MiNK Therapeutics Regains Full Compliance with Nasdaq Listing Requirements [Yahoo! Finance]

MiNK Therapeutics, Inc.  (INKT) 
PDF company pioneering the discovery, development, and commercialization of allogeneic, off-the-shelf invariant natural killer T (iNKT) cell therapies for cancer and other i [Read more]